[Coagulation and complement crosstalk: molecular mechanisms of complement-mediated diseases]
Hiroshi Tsujimoto1, Norimitsu Inoue1
1Department of Molecular Genetics, Wakayama Medical University.
Summary
The complement and coagulation systems interact, contributing to thrombosis in certain diseases. Blocking complement activation, for example with eculizumab, can prevent blood clots in these conditions.
Area of Science:
- * Biochemistry and Immunology
- * Hematology and Thrombosis
Background:
- * The complement and coagulation systems are ancient serine protease cascades involved in host defense and hemostasis.
- * These systems exhibit significant crosstalk, influencing each other's activation and amplifying biological responses.
- * Dysregulation of complement activation is implicated in thrombotic complications across various diseases.
Purpose of the Study:
- * To review the intricate relationship between the complement and coagulation systems.
- * To elucidate the mechanisms by which complement activation contributes to thrombosis.
- * To discuss the therapeutic implications of targeting the complement system for thromboprophylaxis.
Main Methods:
- * Literature review of scientific publications on complement-coagulation interactions.
- * Analysis of disease mechanisms involving complement-mediated thrombosis.
- * Examination of clinical data on anti-complement therapies.
Main Results:
- * Complement activation enhances platelet aggregation and tissue factor expression, promoting coagulation.
- * Activated platelets and coagulation factors can, in turn, activate the complement system.
- * Complement-mediated thrombosis is a feature of diseases like paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome.
Conclusions:
- * The interplay between complement and coagulation is crucial in thrombotic disorders.
- * Targeting the complement system, particularly C5, offers effective thromboprophylaxis in complement-related diseases.
- * Emerging anti-complement agents hold promise for novel antithrombotic strategies.
Related Concept Videos
01:27Complement System
2.3K
The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
2.3K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
672
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
672
01:20Extrinsic and Intrinsic Pathways of Hemostasis
7.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.0K
01:23Antimicrobial Proteins
974
Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
974
01:26Antibody Actions
1.1K
Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
1.1K
01:09Coagulation
6.1K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
6.1K